Pharmaceutical

Oragenics acquires neurological assets from Odyssey Health

Oragenics has concluded the announced acquisition of assets focusing on neurological drug therapies and technologies from Odyssey Health.

Jan 3, 2024 - 18:00
Oragenics acquires neurological assets from Odyssey Health
Oragenics has concluded the announced acquisition of assets focusing on neurological drug therapies and technologies from Odyssey Health.
Read the original article

Tags:

Previous Article

UK MHRA introduces new procedure for medicine approvals

Next Article

EMA validates BMS’s repotrectinib application to treat cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A new study of sick infants sees potential in DNA sequencing, but also a need for better ways to interpret the genome

A new study of sick infants sees potential in DNA seque...

Jul 12, 2023

PBCAR-19B by Precision Biosciences for Mantle Cell Lymp...

Oct 29, 2023

CRISPR-based Casgevy is made accessible in England following NICE guidance

CRISPR-based Casgevy is made accessible in England foll...

Aug 9, 2024